BE884012A - Procede de production d'un vecteur de clonage duplicable comportant un gene quasi-synthetique codant une proteine, vecteur de clonage ainsi obtenu et procede d'obtention de la proteine codee par le gene quasi-synthetique - Google Patents

Procede de production d'un vecteur de clonage duplicable comportant un gene quasi-synthetique codant une proteine, vecteur de clonage ainsi obtenu et procede d'obtention de la proteine codee par le gene quasi-synthetique

Info

Publication number
BE884012A
BE884012A BE1/9864A BE1009864A BE884012A BE 884012 A BE884012 A BE 884012A BE 1/9864 A BE1/9864 A BE 1/9864A BE 1009864 A BE1009864 A BE 1009864A BE 884012 A BE884012 A BE 884012A
Authority
BE
Belgium
Prior art keywords
quasi
cloning vector
synthetic gene
protein
duplicable
Prior art date
Application number
BE1/9864A
Other languages
English (en)
Inventor
D V Goeddel
H L Heyneker
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26733870&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE884012(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of BE884012A publication Critical patent/BE884012A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185—Escherichia
    • C12R2001/19—Escherichia coli
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
BE1/9864A 1979-07-05 1980-06-26 Procede de production d'un vecteur de clonage duplicable comportant un gene quasi-synthetique codant une proteine, vecteur de clonage ainsi obtenu et procede d'obtention de la proteine codee par le gene quasi-synthetique BE884012A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/055,126 US4342832A (en) 1979-07-05 1979-07-05 Method of constructing a replicable cloning vehicle having quasi-synthetic genes

Publications (1)

Publication Number Publication Date
BE884012A true BE884012A (fr) 1980-12-29

Family

ID=26733870

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/9864A BE884012A (fr) 1979-07-05 1980-06-26 Procede de production d'un vecteur de clonage duplicable comportant un gene quasi-synthetique codant une proteine, vecteur de clonage ainsi obtenu et procede d'obtention de la proteine codee par le gene quasi-synthetique

Country Status (42)

Country Link
US (7) US4342832A (fr)
EP (1) EP0022242B1 (fr)
JP (4) JPH0612996B2 (fr)
KR (2) KR830003574A (fr)
AR (1) AR244341A1 (fr)
AT (1) ATE82324T1 (fr)
AU (2) AU533697B2 (fr)
BE (1) BE884012A (fr)
BG (1) BG41135A3 (fr)
BR (1) BR8008736A (fr)
CA (2) CA1164375A (fr)
CH (1) CH661939A5 (fr)
CS (3) CS250652B2 (fr)
DD (3) DD157343A5 (fr)
DE (3) DE3023627A1 (fr)
DK (2) DK173503B1 (fr)
EG (1) EG14819A (fr)
ES (2) ES493149A0 (fr)
FI (2) FI802030A (fr)
FR (2) FR2460330B1 (fr)
GB (2) GB2055382B (fr)
GR (1) GR69320B (fr)
HK (3) HK87484A (fr)
IE (3) IE50460B1 (fr)
IL (3) IL69492A (fr)
IT (1) IT1131393B (fr)
KE (3) KE3446A (fr)
MX (1) MX172674B (fr)
MY (3) MY8500765A (fr)
NL (1) NL930114I2 (fr)
NO (2) NO167673C (fr)
NZ (2) NZ201312A (fr)
OA (1) OA06562A (fr)
PH (1) PH19814A (fr)
PL (1) PL149278B1 (fr)
PT (1) PT71487A (fr)
RO (1) RO93374B (fr)
SG (1) SG56984G (fr)
WO (1) WO1981000114A1 (fr)
YU (3) YU163580A (fr)
ZA (1) ZA803600B (fr)
ZW (1) ZW14180A1 (fr)

Families Citing this family (185)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4342832A (en) * 1979-07-05 1982-08-03 Genentech, Inc. Method of constructing a replicable cloning vehicle having quasi-synthetic genes
US4898830A (en) * 1979-07-05 1990-02-06 Genentech, Inc. Human growth hormone DNA
US6455275B1 (en) 1980-02-25 2002-09-24 The Trustees Of Columbia University In The City Of New York DNA construct for producing proteinaceous materials in eucaryotic cells
CA1200773A (fr) * 1980-02-29 1986-02-18 William J. Rutter Liens d'expression
US4711843A (en) * 1980-12-31 1987-12-08 Cetus Corporation Method and vector organism for controlled accumulation of cloned heterologous gene products in Bacillus subtilis
ZA811368B (en) * 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
IL59690A (en) * 1980-03-24 1983-11-30 Yeda Res & Dev Production of bovine growth hormone by microorganisms and modified microorganisms adapted to produce it
US4370417A (en) * 1980-04-03 1983-01-25 Abbott Laboratories Recombinant deoxyribonucleic acid which codes for plasminogen activator
US6610830B1 (en) 1980-07-01 2003-08-26 Hoffman-La Roche Inc. Microbial production of mature human leukocyte interferons
IE53166B1 (en) * 1980-08-05 1988-08-03 Searle & Co Synthetic urogastrone gene,corresponding plasmid recombinants,transformed cells,production thereof and urogastrone expression
US7101981B1 (en) 1980-08-26 2006-09-05 Regents Of The University Of California Bovine growth hormone recombinantly produced in E. coli
US4725549A (en) * 1980-09-22 1988-02-16 The Regents Of The University Of California Human and rat prolactin and preprolactin cloned genes
FR2490675B1 (fr) * 1980-09-25 1985-11-15 Genentech Inc Production microbienne d'interferon de fibroplaste humain
NZ199722A (en) * 1981-02-25 1985-12-13 Genentech Inc Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain
JPS57181098A (en) * 1981-04-30 1982-11-08 Japan Found Cancer Novel recombinant dna
US4810645A (en) * 1981-08-14 1989-03-07 Hoffmann-La Roche Inc. Microbial production of mature human leukocyte interferon K and L
US4801685A (en) * 1981-08-14 1989-01-31 Hoffmann-La Roche Inc. Microbial production of mature human leukocyte interferon K and L
US5254463A (en) * 1981-09-18 1993-10-19 Genentech, Inc. Method for expression of bovine growth hormone
US4880910A (en) * 1981-09-18 1989-11-14 Genentech, Inc. Terminal methionyl bovine growth hormone and its use
NZ201918A (en) * 1981-09-18 1987-04-30 Genentech Inc N-terminal methionyl analogues of bovine growth hormone
US5236831A (en) * 1981-12-29 1993-08-17 Kiowa Hakko Kogyo Co., Ltd. Amino acid synthesis in corynebacteria using E. coli genes
US4775622A (en) * 1982-03-08 1988-10-04 Genentech, Inc. Expression, processing and secretion of heterologous protein by yeast
US4665160A (en) * 1982-03-22 1987-05-12 Genentech, Inc. Novel human growth hormone like protein HGH-V encoded in the human genome
US4446235A (en) * 1982-03-22 1984-05-01 Genentech, Inc. Method for cloning human growth hormone varient genes
US6936694B1 (en) * 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
US4652639A (en) * 1982-05-06 1987-03-24 Amgen Manufacture and expression of structural genes
EP0095361B1 (fr) * 1982-05-25 1989-07-26 Eli Lilly And Company Vecteurs de clonage pour l'expression de protéine exogène
US4778759A (en) * 1982-07-09 1988-10-18 Boyce, Thompson Institute For Plant Research, Inc. Genetic engineering in cyanobacteria
US4891315A (en) * 1982-10-25 1990-01-02 American Cyanamid Company Production of herpes simplex viral porteins
JPS59501533A (ja) * 1982-08-10 1984-08-30 ザ　トラステイ−　オブ　コロンビア　ユニバ−シテイ−　イン　ザ　シテイ　オブ　ニユ−　ヨ−ク 蛋白質様物質の製造における真生核促進体連鎖の使用
US4530904A (en) * 1982-09-03 1985-07-23 Eli Lilly And Company Method for conferring bacteriophage resistance to bacteria
WO1984001150A1 (fr) * 1982-09-16 1984-03-29 Amgen Hormone de croissance d'aviens
CA1209501A (fr) * 1982-09-16 1986-08-12 Nikos Panayotatos Vecteur d'expression
US4666839A (en) * 1982-12-01 1987-05-19 Amgen Methods and materials for obtaining microbial expression of polypeptides including bovine prolactin
JPS59106297A (ja) * 1982-12-07 1984-06-19 Rikagaku Kenkyusho ヒト生長ホルモンのカルボキシ末端遺伝子の合成法
US5618697A (en) * 1982-12-10 1997-04-08 Novo Nordisk A/S Process for preparing a desired protein
DK55685A (da) * 1985-02-07 1986-08-08 Nordisk Gentofte Enzym eller enzymkompleks med proteolytisk aktivitet
US4634678A (en) * 1982-12-13 1987-01-06 Molecular Genetics Research And Development Limited Partnership Plasmid cloning and expression vectors for use in microorganisms
GB8303383D0 (en) * 1983-02-08 1983-03-16 Biogen Nv Sequences recombinant dna molecules
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4859600A (en) * 1983-04-25 1989-08-22 Genentech, Inc. Recombinant procaryotic cell containing correctly processed human growth hormone
US4755465A (en) * 1983-04-25 1988-07-05 Genentech, Inc. Secretion of correctly processed human growth hormone in E. coli and Pseudomonas
IL71991A (en) * 1983-06-06 1994-05-30 Genentech Inc Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes
BG49718A3 (en) * 1983-07-15 1992-01-15 Bio Technology General Corp Method for preparing of polypeptid with superoxiddismutasne activitty
US5242798A (en) * 1983-07-21 1993-09-07 Scripps Clinic And Research Foundation Synthetic polypeptides corresponding to portions of proteinoids translated from brain-specific mRNAs, receptors, methods and diagnostics using the same
US4900811A (en) * 1983-07-21 1990-02-13 Scripps Clinic And Research Foundation Synthetic polypeptides corresponding to portions of proteinoids translated from brain-specific mRNAs, receptors, methods and diagnostics using the same
JPS60137291A (ja) * 1983-12-26 1985-07-20 Takeda Chem Ind Ltd 発現ベクター
CA1213537A (fr) * 1984-05-01 1986-11-04 Canadian Patents And Development Limited - Societe Canadienne Des Brevets Et D'exploitation Limitee Methode d'expression de polypeptides
CA1272144A (fr) * 1984-06-29 1990-07-31 Tamio Mizukami Hormone de croissance polypeptidique pour les poissons
US5489529A (en) * 1984-07-19 1996-02-06 De Boer; Herman A. DNA for expression of bovine growth hormone
WO1986002068A1 (fr) * 1984-09-26 1986-04-10 Takeda Chemical Industries, Ltd. Separation mutuelle de proteines
EP0177343B1 (fr) * 1984-10-05 1992-07-22 Genentech, Inc. ADN, cultures de cellules et méthodes pour sécréter des protéines hétérologiques et récupérer des protéines périplasmiques
US4680262A (en) * 1984-10-05 1987-07-14 Genentech, Inc. Periplasmic protein recovery
NZ213759A (en) * 1984-10-19 1989-01-27 Genentech Inc Lhrh-ctp protein conjugates influencing prolactin fsh and lh release
US4645829A (en) * 1984-10-29 1987-02-24 Monsanto Company Method for separating polypeptides
US4652630A (en) * 1985-02-22 1987-03-24 Monsanto Company Method of somatotropin naturation
US4861868A (en) * 1985-02-22 1989-08-29 Monsanto Company Production of proteins in procaryotes
DK151585D0 (da) * 1985-04-03 1985-04-03 Nordisk Gentofte Dna-sekvens
DE3683186D1 (de) * 1985-04-25 1992-02-13 Hoffmann La Roche Rekombinantes humaninterleukin-1.
JP2703893B2 (ja) * 1985-07-05 1998-01-26 ホワイトヘッド・インスティテュ−ト・フォ−・バイオメディカル・リサ−チ 外来遺伝子物質を発現する上皮細胞
US5041381A (en) 1986-07-03 1991-08-20 Schering Corporation Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
US4892764A (en) * 1985-11-26 1990-01-09 Loctite Corporation Fiber/resin composites, and method of making the same
US5827826A (en) * 1986-03-03 1998-10-27 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compositions of human endothelial cell growth factor
US5552528A (en) 1986-03-03 1996-09-03 Rhone-Poulenc Rorer Pharmaceuticals Inc. Bovine b-endothelial cell growth factor
EP0245218B1 (fr) * 1986-05-07 1993-12-29 ENIRICERCHE S.p.A. Vecteur de plasmide pour l'expression dans les bacilles utilisé pour cloner le gène pour l'hormone humaine de croissance et un procédé pour préparer l'hormone
EP0252588A3 (fr) * 1986-05-12 1989-07-12 Smithkline Beecham Corporation Procédé d'isolation et de purification de la protéine CS du P. falciparum exprimée dans E. coli recombinant, ainsi que son utilisation comme vaccin
US4806239A (en) * 1986-11-28 1989-02-21 Envirotech Corporation Apparatus for shifting filter plates in a filter press
JPS63159244A (ja) * 1986-12-23 1988-07-02 三菱マテリアル株式会社 二層の押出成形珪酸質―石灰質系成形品の製造方法
JPH0720436B2 (ja) * 1986-12-31 1995-03-08 株式会社ラッキー 合成遺伝子を使用したサケ成長ホルモンの製造方法
EP0329710A1 (fr) * 1987-01-07 1989-08-30 Allied Corporation Production microbienne d'oligomeres peptidiques
US4977089A (en) * 1987-01-30 1990-12-11 Eli Lilly And Company Vector comprising signal peptide-encoding DNA for use in Bacillus and other microorganisms
WO1988010119A1 (fr) * 1987-06-22 1988-12-29 Genetics Institute, Inc. Nouvelles proteines thrombolytiques
FR2624835B2 (fr) * 1987-08-05 1990-09-07 Hassevelde Roger Support ergonomique a creme glacee, a cuillere integree, transformable en tout autre objet apres son utilisation premiere
US5268267A (en) * 1987-08-21 1993-12-07 The General Hospital Corporation Method for diagnosing small cell carcinoma
IT1223577B (it) * 1987-12-22 1990-09-19 Eniricerche Spa Procedimento migliorato per la preparazione dell'ormone della crescita umano naturale in forma pura
JPH0231042U (fr) * 1988-08-19 1990-02-27
US5130422A (en) * 1988-08-29 1992-07-14 Monsanto Company Variant somatotropin-encoding DNA
WO1990002762A1 (fr) 1988-09-02 1990-03-22 The Rockefeller University Mediateur inflammatoire derive de macrophages (mip-2)
US5079230A (en) * 1988-09-12 1992-01-07 Pitman-Moore, Inc. Stable bioactive somatotropins
US5082767A (en) * 1989-02-27 1992-01-21 Hatfield G Wesley Codon pair utilization
US5075227A (en) * 1989-03-07 1991-12-24 Zymogenetics, Inc. Directional cloning
US4960301A (en) * 1989-03-27 1990-10-02 Fry Steven A Disposable liner for pickup truck beds
US5164180A (en) 1989-05-18 1992-11-17 Mycogen Corporation Bacillus thuringiensis isolates active against lepidopteran pests
US5266477A (en) * 1990-02-02 1993-11-30 Pitman-Moore, Inc. Monoclonal antibodies which differentiate between native and modified porcine somatotropins
CA2041446A1 (fr) 1990-05-15 1991-11-16 August J. Sick Genes de bacillus thuringiensis qui codent pour des toxines qui sont efficaces contre les dipteres
US5849694A (en) * 1990-07-16 1998-12-15 Synenki; Richard M. Stable and bioactive modified porcine somatotropin and pharmaceutical compositions thereof
US5744139A (en) * 1991-06-28 1998-04-28 University Of Tennessee Research Corporation Insulin-like growth factor I (IGF-1) induced improvement of depressed T4/T8 ratios
US5202119A (en) * 1991-06-28 1993-04-13 Genentech, Inc. Method of stimulating immune response
HUT67319A (en) * 1991-08-30 1995-03-28 Life Medical Sciences Inc Compositions for treating wounds
US5591709A (en) * 1991-08-30 1997-01-07 Life Medical Sciences, Inc. Compositions and methods for treating wounds
US5317012A (en) * 1991-10-04 1994-05-31 The University Of Tennessee Research Corporation Human growth hormone induced improvement in depressed T4/T8 ratio
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
AU5446494A (en) * 1992-10-22 1994-05-09 Sloan-Kettering Institute For Cancer Research Growth hormone fragment hgh 108-129
EP0752853B1 (fr) 1993-03-10 2005-09-21 Smithkline Beecham Corporation Phosphodiesterase du cerveau humain
FR2738842B1 (fr) * 1995-09-15 1997-10-31 Rhone Poulenc Rorer Sa Molecule d'adn circulaire a origine de replication conditionnelle, leur procede de preparation et leur utilisation en therapie genique
GB9526733D0 (en) * 1995-12-30 1996-02-28 Delta Biotechnology Ltd Fusion proteins
US5760187A (en) * 1996-02-22 1998-06-02 Mitsui Toatsu Chemicals, Inc. Purification process of a human growth hormone
JP3794748B2 (ja) * 1996-03-04 2006-07-12 第一アスビオファーマ株式会社 メタノール代謝系を有する微生物の培養法
US6503729B1 (en) 1996-08-22 2003-01-07 The Board Of Trustees Of The University Of Illinois Selected polynucleotide and polypeptide sequences of the methanogenic archaeon, methanococcus jannashii
MX9605082A (es) * 1996-10-24 1998-04-30 Univ Autonoma De Nuevo Leon Levaduras metilotroficas modificadas geneticamente para la produccion y secrecion de hormona de crecimiento humano.
EP1007069A1 (fr) * 1996-11-01 2000-06-14 Smithkline Beecham Corporation Nouvelles sequences codantes
US6068991A (en) * 1997-12-16 2000-05-30 Bristol-Myers Squibb Company High expression Escherichia coli expression vector
CA2314429C (fr) 1997-12-18 2010-03-02 Ecogen, Inc. Plantes transgeniques resistant aux insectes et procedes permettant d'ameliorer l'activite de l'.delta.-endotoxine contre des insectes cibles
US6087128A (en) * 1998-02-12 2000-07-11 Ndsu Research Foundation DNA encoding an avian E. coli iss
DE69840035D1 (de) 1998-03-31 2008-10-30 Tonghua Gantech Biotechnology Chimäres protein welches eine intramolekulare chap zur insulinproduktion
US6271444B1 (en) 1998-07-10 2001-08-07 Calgene Llc Enhancer elements for increased translation in plant plastids
US6512162B2 (en) 1998-07-10 2003-01-28 Calgene Llc Expression of eukaryotic peptides in plant plastids
JP2002525587A (ja) 1998-08-28 2002-08-13 フェビット フェラリウス バイオテクノロジー ゲゼルシャフト ミット ベシュレンクテル ハフツング 試料中の分析物を測定するための方法および装置
DE50013228D1 (de) 1999-02-19 2006-09-07 Febit Biotech Gmbh Verfahren zur herstellung von polymeren
US6946265B1 (en) 1999-05-12 2005-09-20 Xencor, Inc. Nucleic acids and proteins with growth hormone activity
US6187750B1 (en) 1999-08-25 2001-02-13 Everyoung Technologies, Inc. Method of hormone treatment for patients with symptoms consistent with multiple sclerosis
AT408721B (de) 1999-10-01 2002-02-25 Cistem Biotechnologies Gmbh Pharmazeutische zusammensetzung enthaltend ein antigen
GB9924351D0 (en) 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
US6562790B2 (en) 2000-02-05 2003-05-13 Chein Edmund Y M Hormone therapy methods and hormone products for abating coronary artery blockage
AU2001259063A1 (en) 2000-04-12 2001-10-30 Human Genome Sciences, Inc. Albumin fusion proteins
US6995246B1 (en) * 2000-10-19 2006-02-07 Akzo Nobel N.V. Methods for removing suspended particles from soluble protein solutions
AU2002224124A1 (en) 2000-12-01 2002-06-11 Takeda Chemical Industries Ltd. Method for producing preparation containing bioactive substance
WO2002046435A2 (fr) * 2000-12-05 2002-06-13 Alexion Pharmaceuticals, Inc. Plasmides modifies utilises pour la production in situ de genes
US20020164712A1 (en) * 2000-12-11 2002-11-07 Tonghua Gantech Biotechnology Ltd. Chimeric protein containing an intramolecular chaperone-like sequence
WO2002097038A2 (fr) * 2001-05-25 2002-12-05 Human Genome Sciences, Inc. Proteines hybrides beta-1 de chimiokine
US6720538B2 (en) * 2001-06-18 2004-04-13 Homedics, Inc. Thermostat variation compensating knob
DK1578771T3 (da) 2001-10-10 2013-06-10 Novo Nordisk As Remodellering og glycokonjugering af peptider
US20030171285A1 (en) * 2001-11-20 2003-09-11 Finn Rory F. Chemically-modified human growth hormone conjugates
WO2003059934A2 (fr) 2001-12-21 2003-07-24 Human Genome Sciences, Inc. Proteines de fusion d'albumine
EP1463751B1 (fr) 2001-12-21 2013-05-22 Human Genome Sciences, Inc. Proteines hybrides d'albumine
EP1539960B1 (fr) * 2002-09-09 2010-04-28 Hanall Pharmaceutical Co., Ltd. Polypeptides modifiés d'interferon alpha résistant aux protéases
TWI281864B (en) * 2002-11-20 2007-06-01 Pharmacia Corp N-terminally monopegylated human growth hormone conjugates and process for their preparation
BR0317888A (pt) * 2002-12-31 2005-12-06 Altus Pharmaceuticals Inc Cristais do hormÈnio do crescimento humano e processos para preparação dos mesmos
EP1594530A4 (fr) 2003-01-22 2006-10-11 Human Genome Sciences Inc Proteines hybrides d'albumine
WO2004074345A2 (fr) * 2003-02-19 2004-09-02 Pharmacia Corporation Esters de polyethyleneglycol actives
AU2004235875A1 (en) * 2003-05-09 2004-11-18 Pharmexa A/S Immunogenic human TNF alpha analogues with reduced cytotoxicity and methods of their preparation
JP2007519422A (ja) 2004-02-02 2007-07-19 アンブレツクス・インコーポレイテツド 修飾されたヒト四螺旋バンドルポリペプチド及びそれらの使用
US7820409B2 (en) * 2004-06-23 2010-10-26 Usv, Ltd. Chimeric human growth hormone derived from the placenta and pituitary isoform and processes for obtaining said chimera
US8282921B2 (en) * 2004-08-02 2012-10-09 Paul Glidden tRNA synthetase fragments
US20060024288A1 (en) * 2004-08-02 2006-02-02 Pfizer Inc. tRNA synthetase fragments
US7998930B2 (en) 2004-11-04 2011-08-16 Hanall Biopharma Co., Ltd. Modified growth hormones
BRPI0519430A2 (pt) * 2004-12-22 2009-02-10 Ambrx Inc hormânio do crescimento humano modificado
AU2005322019B2 (en) * 2004-12-22 2010-08-26 Ambrx, Inc. Formulations of human growth hormone comprising a non-naturally encoded amino acid
SG161210A1 (en) * 2004-12-22 2010-05-27 Ambrx Inc Methods for expression and purification of recombinant human growth hormone
WO2006121569A2 (fr) 2005-04-08 2006-11-16 Neose Technologies, Inc. Compositions et methodes utilisees pour la preparation de mutants par glycosylation de l'hormone de croissance humaine resistant a la protease
EP1896134A2 (fr) 2005-06-13 2008-03-12 Rigel Pharmaceuticals, Inc. Methodes et compositions de traitement de maladies osseuses degeneratives
US8030271B2 (en) * 2005-07-05 2011-10-04 Emisphere Technologies, Inc. Compositions and methods for buccal delivery of human growth hormone
WO2007019646A1 (fr) * 2005-08-19 2007-02-22 University Of Technology, Sydney Thérapie de gène dans le foie
EP2339014B1 (fr) 2005-11-16 2015-05-27 Ambrx, Inc. Procédés et compositions comprenant des acides aminés non naturels
JP2009521486A (ja) * 2005-12-23 2009-06-04 アルタス ファーマシューティカルズ インコーポレイテッド ポリカチオン錯化タンパク質結晶を含む組成物およびこれを使用した治療法
DE102006039479A1 (de) 2006-08-23 2008-03-06 Febit Biotech Gmbh Programmierbare Oligonukleotidsynthese
JP2010513309A (ja) 2006-12-18 2010-04-30 アルタス ファーマシューティカルズ インコーポレイテッド ヒト成長ホルモン製剤
US20080260820A1 (en) * 2007-04-19 2008-10-23 Gilles Borrelly Oral dosage formulations of protease-resistant polypeptides
CN101784655A (zh) * 2007-04-27 2010-07-21 菲尼克斯股份有限公司 可溶性重组二十面体病毒样颗粒的改良生成和体内装配
SI2147105T1 (sl) 2007-05-02 2013-08-30 Merial Limited DNA-plazmidi z izboljšano ekspresijo in stabilnostjo
WO2009012502A1 (fr) * 2007-07-19 2009-01-22 The Arizona Board Of Regents, A Body Corporate Of The State Of Arizona Acting For And On Behalf Of Arizona State University Électrode neurale intrafasciculaire à mems à auto-ancrage
US7939447B2 (en) * 2007-10-26 2011-05-10 Asm America, Inc. Inhibitors for selective deposition of silicon containing films
SG188143A1 (en) 2008-02-08 2013-03-28 Ambrx Inc Modified leptin polypeptides and their uses
JP6112766B2 (ja) 2008-04-29 2017-04-12 アセンディス ファーマ グロウス ディスオーダーズ ディヴィジョン エー／エス Ｐｅｇ化された組換えヒト成長ホルモン化合物
KR20110028258A (ko) * 2008-04-30 2011-03-17 그래댈리스, 인코포레이티드 고순도 플라스미드 ｄｎａ 제제 및 이의 제조방법
MX2010014078A (es) * 2008-06-25 2011-04-11 Braasch Biotech Llc Composiciones y metodos para inmunogenecidad mejorada de somatostatina.
JP5506792B2 (ja) 2008-06-25 2014-05-28 ブラーシュ・バイオテック・エルエルシー クロラムフェニコールアセチルトランスフェラーゼ（ｃａｔ）不完全ソマトスタチン融合タンパク質およびその使用
MX362028B (es) 2009-02-03 2019-01-04 Amunix Pharmaceuticals Inc Polipeptidos recombinantes extendidos y composiciones que comprenden los mismos.
US8703717B2 (en) * 2009-02-03 2014-04-22 Amunix Operating Inc. Growth hormone polypeptides and methods of making and using same
US9238878B2 (en) 2009-02-17 2016-01-19 Redwood Bioscience, Inc. Aldehyde-tagged protein-based drug carriers and methods of use
EP2398915B1 (fr) 2009-02-20 2016-08-24 Synthetic Genomics, Inc. Synthèse d'acides nucléiques à séquence vérifiée
US9849188B2 (en) 2009-06-08 2017-12-26 Amunix Operating Inc. Growth hormone polypeptides and methods of making and using same
AU2010290077C1 (en) 2009-08-24 2015-12-03 Bioverativ Therapeutics Inc. Coagulation factor IX compositions and methods of making and using same
NZ600361A (en) 2009-12-21 2014-06-27 Ambrx Inc Modified bovine somatotropin polypeptides and their uses
CN104017063A (zh) 2009-12-21 2014-09-03 Ambrx公司 经过修饰的猪促生长素多肽和其用途
EP2536749A1 (fr) 2010-02-17 2012-12-26 Elona Biotechnologies Hgh et procédés de préparation de hgh
EP2446898A1 (fr) 2010-09-30 2012-05-02 Laboratorios Del. Dr. Esteve, S.A. Utilisation de l'hormone de croissance pour améliorer la réponse immunitaire chez des patients immunodéprimés
CN103415621A (zh) 2011-01-14 2013-11-27 雷德伍德生物科技股份有限公司 醛标记免疫球蛋白多肽及其使用方法
RU2473556C1 (ru) * 2011-07-14 2013-01-27 Закрытое акционерное общество "ГЕНЕРИУМ" Промышленный способ получения и очистки рекомбинантного гормона роста человека из телец включения
SG10201604810UA (en) 2012-02-07 2016-08-30 Global Bio Therapeutics Inc Compartmentalized method of nucleic acid delivery and compositions and uses thereof
ES2771208T3 (es) 2012-02-15 2020-07-06 Bioverativ Therapeutics Inc Composiciones de factor VIII y métodos de preparación y uso de las mismas
EP3549953A1 (fr) 2012-02-15 2019-10-09 Bioverativ Therapeutics Inc. Protéines de facteur viii de recombinaison
JP2015518470A (ja) 2012-03-26 2015-07-02 プロニュートリア・インコーポレイテッドＰｒｏｎｕｔｒｉａ， Ｉｎｃ． 栄養タンパク質および方法
CN104470946A (zh) 2012-03-26 2015-03-25 普罗努塔利亚公司 带电荷营养性蛋白质和方法
SG11201405841RA (en) 2012-03-26 2014-10-30 Pronutria Inc Nutritive fragments, proteins and methods
WO2013148325A1 (fr) 2012-03-26 2013-10-03 Pronutria, Inc. Fragments nutritifs, protéines nutritives et procédés
US9457096B2 (en) 2012-07-06 2016-10-04 Consejo Nacional De Investigaciones Cientificas Y Tecnicas (Concet) Protozoan variant-specific surface proteins (VSP) as carriers for oral drug delivery
MX2016001667A (es) 2013-08-08 2016-11-07 Global Bio Therapeutics Inc Dispositivo de sujecion para procedimientos minimamente invasivos y usos del mismo.
WO2015023891A2 (fr) 2013-08-14 2015-02-19 Biogen Idec Ma Inc. Fusions de facteur vii-xten et leurs utilisations
EP3048904A2 (fr) 2013-09-25 2016-08-03 Pronutria Biosciences, Inc. Compositions et formulations pour le traitement des maladies de malabsorption et les affections inflammatoires des voies gastro-intestinales, leurs procédés de production et d'utilisation
HRP20211734T8 (hr) 2014-11-21 2022-03-04 Ascendis Pharma Endocrinology Division A/S Dozni oblici dugodjelujućeg hormona rasta
EA201890423A1 (ru) 2015-08-03 2018-07-31 Биовератив Терапьютикс Инк. Слитые белки фактора ix, способы их получения и применения
JP2019515677A (ja) 2016-04-26 2019-06-13 アール．ピー．シェーラー テクノロジーズ エルエルシー 抗体複合体ならびにそれを作製および使用する方法
WO2020004368A1 (fr) 2018-06-25 2020-01-02 Ｊｃｒファーマ株式会社 Formulation liquide aqueuse contenant des protéines
CN109486847B (zh) * 2018-12-17 2021-03-02 江南大学 基于人工串联启动子的枯草芽孢杆菌高效诱导表达系统

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3853833A (en) * 1971-04-27 1974-12-10 Hormone Res Foundation Synthetic human growth-promoting and lactogenic hormones and method of producing same
US3853832A (en) * 1971-04-27 1974-12-10 Harmone Res Foundation Synthetic human pituitary growth hormone and method of producing it
GB1521032A (en) * 1974-08-08 1978-08-09 Ici Ltd Biological treatment
US4237224A (en) * 1974-11-04 1980-12-02 Board Of Trustees Of The Leland Stanford Jr. University Process for producing biologically functional molecular chimeras
NL7607683A (nl) * 1976-07-12 1978-01-16 Akzo Nv Werkwijze ter bereiding van nieuwe peptiden en peptide-derivaten en de toepassing hiervan.
US4190495A (en) * 1976-09-27 1980-02-26 Research Corporation Modified microorganisms and method of preparing and using same
US4363877B1 (en) * 1977-09-23 1998-05-26 Univ California Recombinant dna transfer vectors
NZ187300A (en) * 1977-05-27 1982-08-17 Univ California Dna transfer vector and micro-organism modified to contain a nucleotide sequence equivalent to the gene of a higher organism
CH630089A5 (de) * 1977-09-09 1982-05-28 Ciba Geigy Ag Verfahren zur herstellung von siliciummodifizierten imidyl-phthalsaeurederivaten.
JPS5449837A (en) * 1977-09-19 1979-04-19 Kobashi Kogyo Kk Safety apparatus of soil block making machine
US4407948A (en) * 1977-09-23 1983-10-04 The Regents Of The University Of California Purification of nucleotide sequences suitable for expression in bacteria
ZA782933B (en) * 1977-09-23 1979-05-30 Univ California Purification of nucleotide sequences suitable for expression in bacteria
US4321365A (en) * 1977-10-19 1982-03-23 Research Corporation Oligonucleotides useful as adaptors in DNA cloning, adapted DNA molecules, and methods of preparing adaptors and adapted molecules
ES474849A1 (es) * 1977-11-08 1979-12-01 Genentech Inc Mejoras en un proceso para la produccion de un producto que comprende un polipeptido especifico
US4356270A (en) * 1977-11-08 1982-10-26 Genentech, Inc. Recombinant DNA cloning vehicle
AT373281B (de) * 1977-11-08 1984-01-10 Genentech Inc Verfahren zur herstellung eines strukturgens
DK173092B1 (da) * 1977-11-08 2000-01-10 Genentech Inc Rekombinant plasmid, fremgangsmåde til fremstilling af plasmidet, bakterie indeholdende plasmidet, samt fremgangsmåde til f
US4366246A (en) * 1977-11-08 1982-12-28 Genentech, Inc. Method for microbial polypeptide expression
BR7807288A (pt) * 1977-11-08 1979-06-12 Genentech Inc Processo para sintese de polinucleotidos
US4652525A (en) * 1978-04-19 1987-03-24 The Regents Of The University Of California Recombinant bacterial plasmids containing the coding sequences of insulin genes
US4411994A (en) * 1978-06-08 1983-10-25 The President And Fellows Of Harvard College Protein synthesis
US4565785A (en) * 1978-06-08 1986-01-21 The President And Fellows Of Harvard College Recombinant DNA molecule
FI792481A (fi) * 1978-08-11 1980-02-12 Univ California Syntes av enkaroytiskt protein genom anvaendning av mikro-organismer
EP0009930B2 (fr) * 1978-10-10 1988-08-24 The Board Of Trustees Of The Leland Stanford Junior University DNA recombinant, méthode pour sa préparation et production de protéines étrangères par des hôtes unicellulaires le contenant
US4332892A (en) * 1979-01-15 1982-06-01 President And Fellows Of Harvard College Protein synthesis
IE52036B1 (en) * 1979-05-24 1987-05-27 Univ California Non-passageable viruses
ZA802992B (en) * 1979-06-01 1981-10-28 Univ California Human pre-growth hormone
US4898830A (en) * 1979-07-05 1990-02-06 Genentech, Inc. Human growth hormone DNA
US4342832A (en) * 1979-07-05 1982-08-03 Genentech, Inc. Method of constructing a replicable cloning vehicle having quasi-synthetic genes
GR70279B (fr) * 1979-09-12 1982-09-03 Univ California
IL59690A (en) * 1980-03-24 1983-11-30 Yeda Res & Dev Production of bovine growth hormone by microorganisms and modified microorganisms adapted to produce it
GR79124B (fr) * 1982-12-22 1984-10-02 Genentech Inc
US4859600A (en) * 1983-04-25 1989-08-22 Genentech, Inc. Recombinant procaryotic cell containing correctly processed human growth hormone
CA1267615A (fr) * 1984-08-27 1990-04-10 Dan Hadary Methode pour la recuperation d'hormones de croissance purifiees a patir de microorganismes modifies par des techniques de genie genetique

Also Published As

Publication number Publication date
JPH05268970A (ja) 1993-10-19
PL225376A1 (en) 1983-07-18
GR69320B (fr) 1982-05-14
KE3446A (en) 1984-10-05
SG56984G (en) 1985-03-08
WO1981000114A1 (fr) 1981-01-22
AU574351B2 (en) 1988-07-07
NO810608L (no) 1981-02-20
US5424199A (en) 1995-06-13
DD210070A5 (de) 1984-05-30
NZ201312A (en) 1983-09-30
US4634677A (en) 1987-01-06
IE50461B1 (en) 1986-04-30
CS250652B2 (en) 1987-05-14
GB2055382A (en) 1981-03-04
DD157343A5 (de) 1982-11-03
IL69492A (en) 1985-04-30
MY8500763A (en) 1985-12-31
IT8023070A0 (it) 1980-06-26
KE3450A (en) 1984-10-05
ZW14180A1 (en) 1980-09-10
PL149278B1 (en) 1990-01-31
DD210071A5 (de) 1984-05-30
US4601980A (en) 1986-07-22
FR2460330A1 (fr) 1981-01-23
US4342832A (en) 1982-08-03
EP0022242B1 (fr) 1992-11-11
AU533697B2 (en) 1983-12-08
ES8105386A1 (es) 1981-05-16
EP0022242A3 (en) 1982-04-07
HK87484A (en) 1984-11-16
CS270884A2 (en) 1987-07-16
KR830003574A (ko) 1983-06-21
MY8500765A (en) 1985-12-31
DK251490D0 (da) 1990-10-18
AU5949880A (en) 1981-01-15
DK173503B1 (da) 2001-01-15
RO93374A (fr) 1988-01-30
GB2055382B (en) 1983-10-19
OA06562A (fr) 1981-07-31
DE3023627A1 (de) 1981-01-22
ATE82324T1 (de) 1992-11-15
FR2518572B1 (fr) 1985-08-23
MY8500764A (en) 1985-12-31
IE50462B1 (en) 1986-04-30
DE3050722C2 (fr) 1987-09-24
FR2518572A1 (fr) 1983-06-24
CA1202256A (fr) 1986-03-25
IL69492A0 (en) 1983-11-30
JPS5621596A (en) 1981-02-28
NO167673C (no) 1991-11-27
YU121183A (en) 1984-02-29
IE50460B1 (en) 1986-04-30
ES8205265A1 (es) 1982-06-01
FR2460330B1 (fr) 1985-07-19
PT71487A (en) 1980-08-01
DK172132B1 (da) 1997-11-24
NO167673B (no) 1991-08-19
KR870000701B1 (ko) 1987-04-07
NO860680L (no) 1981-02-20
FI850198A0 (fi) 1985-01-16
KE3451A (en) 1984-10-05
CA1164375A (fr) 1984-03-27
IE801214L (en) 1981-01-05
HK87384A (en) 1984-11-16
GB2121047A (en) 1983-12-14
JPH0648987B2 (ja) 1994-06-29
JP2622479B2 (ja) 1997-06-18
IL60312A0 (en) 1980-09-16
AR244341A1 (es) 1993-10-29
EP0022242A2 (fr) 1981-01-14
DK97381A (da) 1981-03-04
IL60312A (en) 1985-04-30
ES499043A0 (es) 1982-06-01
PH19814A (en) 1986-07-08
JPH0612996B2 (ja) 1994-02-23
MX172674B (es) 1994-01-06
NZ194043A (en) 1983-09-30
CS250655B2 (en) 1987-05-14
BG41135A3 (en) 1987-04-15
FI802030A (fi) 1981-01-06
CS254973B2 (en) 1988-02-15
ES493149A0 (es) 1981-05-16
YU121283A (en) 1984-02-29
GB2121047B (en) 1984-06-06
IE842193L (en) 1981-01-05
DK251490A (da) 1990-10-18
AU2583484A (en) 1984-07-12
NL930114I2 (nl) 1994-10-17
FI850198L (fi) 1985-01-16
US5795745A (en) 1998-08-18
EG14819A (en) 1985-03-31
NL930114I1 (nl) 1993-10-18
ZA803600B (en) 1981-07-29
JPH08242881A (ja) 1996-09-24
NO167674B (no) 1991-08-19
BR8008736A (pt) 1981-04-28
IT1131393B (it) 1986-06-18
YU163580A (en) 1984-02-29
NO167674C (no) 1991-11-27
US4604359A (en) 1986-08-05
US4658021A (en) 1987-04-14
AU1838883A (en) 1984-01-05
RO93374B (ro) 1988-01-31
HK87584A (en) 1984-11-16
DE3050725C2 (fr) 1988-03-10
CH661939A5 (de) 1987-08-31
JPH02478A (ja) 1990-01-05

Similar Documents

Publication Publication Date Title
FR2460330B1 (fr) Procede de production d'un vecteur de clonage duplicable comportant un gene quasi-synthetique codant une proteine, vecteur de clonage ainsi obtenu et procede d'obtention de la proteine codee par le gene quasi-synthetique
ATE22104T1 (de) Herstellung von pyrrolo-(3,4-c)-pyrrolen.
DE3872495D1 (de) Herstellung von 3,3,3-trifluoropropen.
MA19716A1 (fr) Procede de preparation de nouveaux derives 3- ceto a 4,9 19- norsteroides .
IT8022096A0 (it) Procedimento per la produzione di pasta secca, impianto per la sua attuazione, nonche' prodotto ottenuto.
DE3671696D1 (de) Maschine zur herstellung von individuellen kaffeeportionen nach geschmack.
OA06823A (fr) Procédé d'élaboration d'acier inoxydable.
DE3884254D1 (de) Verfahren zur kontinuierlichen Herstellung von Octa-2,7-dien-1-ol.
IT8619370A0 (it) Molla elicoidale, nonche'procedimento per la sua fabbricazione.
FR2561238B1 (fr) Procede de production de diphenylamines ou de n,n'-diphenyl-phenylenediamines
ZA902843B (en) Soluble interferon-gamma receptors and methods for their production
ES538579A0 (es) Un procedimiento para la produccion de 3,3",4"-tri-o-acilespiramicina i"-.
FR2528070B1 (fr) Vecteur d'expression porteur d'un codage genetique pour une proteine liant les phosphates, procede pour sa preparation et procede de production d'un polypeptide en l'utilisant
YU100381A (en) Process for producing antiinflammatory 4,5-diaryl-alpha-(polyfluoralkyl)-1h-pyrrol-2-metamines
BE848926A (fr) Procede de preparation d'adjuvant alimentaire, en particulier pour les volailles et adjuvant ainsi obtenu
MA19806A1 (fr) Procede de production de polyesters aromatiques et polyesters ainsi obtenus .
DE3561719D1 (en) Process for the preparation of symmetrical benzophenones substituted by fluor-containing groups, their use and symmetrical benzophenones substituted by fluor-containing groups
ATE101846T1 (de) Verfahren zur herstellung von 1,1dichlorotetrafluorethan.
YU61982A (en) Process for producing intermediates useful in the production of 1,1-dioxo-penicillanoyloxy-methyl-6-(2-amino-2-phenylacetamido0penicillanate
DE68917379D1 (de) Verfahren zur Herstellung von Proteinen, die ähnlich dem natürlich-menschlichen Apolipoprotein-E sind.
OA08564A (fr) Nouveaux ortho-anisamides, leur procédé d'obtention et leurs applications thérapeutiques.
DE3762336D1 (de) Kontinuierliches herstellungsverfahren von dichlorhydrin.
FR2566389B1 (fr) Procede de production d'un 1,4-dialkylbenzene
HUT48214A (en) Improved process for producing 3,5-dichloro-2,4,6-trifluoropyridine
DE3161613D1 (en) Process for the production of 3-mercapto-propanediol-(1,2)

Legal Events

Date Code Title Description
CCPA Application for a supplementary protection certificate

Free format text: 093C0167

CCPV Grant of a supplementary protection certificate

Free format text: 093C0167, EXPIRES 20020901

RE20 Patent expired

Owner name: GENENTECH INC.

Effective date: 20000626